The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ACCELERON PHARMA INC COM 00434H108 53,563 1,103,937 SH   SOLE   1,103,937 0 0
AERIE PHARMACEUTICALS INC COM 00771V108 8,538 126,397 SH   SOLE   126,397 0 0
AKEBIA THERAPEUTICS INC COM 00972D105 30,938 3,100,000 SH   SOLE   3,100,000 0 0
AMICUS THERAPEUTICS INC COM 03152W109 16,888 1,081,181 SH   SOLE   1,081,181 0 0
CORVUS PHARMACEUTICALS INC COM 221015100 48,537 4,420,516 SH   SOLE   4,420,516 0 0
DERMIRA INC COM 24983L104 18,342 1,993,746 SH   SOLE   1,993,746 0 0
GLAUKOS CORP COM 377322102 24,494 602,709 SH   SOLE   602,709 0 0
INOGEN INC COM 45780L104 661,345 3,549,320 SH   SOLE   3,549,320 0 0
INVUITY INC COM NEW 46187J205 5,319 1,363,848 SH   SOLE   1,363,848 0 0
MENLO THERAPEUTICS INC COM 586858102 11,663 1,436,313 SH   SOLE   1,436,313 0 0
MERUS N V COM N5749R100 32,101 1,410,417 SH   SOLE   1,410,417 0 0
NABRIVA THERAPEUTICS PLC SHS G63637105 10,053 2,888,720 SH   SOLE   2,888,720 0 0
ORTHOPEDIATRICS CORP COM 68752L100 17,405 653,349 SH   SOLE   653,349 0 0
RA PHARMACEUTICALS INC COM 74933V108 14,585 1,465,838 SH   SOLE   1,465,838 0 0
SEASPINE HLDGS CORP COM 81255T108 11,709 927,788 SH   SOLE   927,788 0 0
UNUM THERAPEUTICS INC COM 903214104 9,545 665,181 SH   SOLE   665,181 0 0
VERONA PHARMA PLC SPONSORED ADS 925050106 10,119 740,740 SH   SOLE   740,740 0 0
WRIGHT MED GROUP N V RIGHT 03/01/2019 N96617126 5,916 4,622,032 PRN   SOLE   0 0 4,622,032